tetano
Editor, Senior Moderator
Cell Discov
. 2023 Jan 6;9(1):2.
doi: 10.1038/s41421-022-00510-2.
Extracellular vesicles mediate antibody-resistant transmission of SARS-CoV-2
Bingqing Xia[SUP] #[/SUP][SUP] 1 2 [/SUP], Xiaoyan Pan[SUP] #[/SUP][SUP] 3 [/SUP], Rong-Hua Luo[SUP] #[/SUP][SUP] 4 [/SUP], Xurui Shen[SUP] #[/SUP][SUP] 5 6 [/SUP], Shuangqu Li[SUP] 5 6 [/SUP], Yi Wang[SUP] 5 6 [/SUP], Xiaoli Zuo[SUP] 5 [/SUP], Yan Wu[SUP] 3 [/SUP], Yingqi Guo[SUP] 7 [/SUP], Gengfu Xiao[SUP] 3 [/SUP], Qiguang Li[SUP] 5 6 [/SUP], Xin-Yan Long[SUP] 4 8 [/SUP], Xiao-Yan He[SUP] 4 8 [/SUP], Hong-Yi Zheng[SUP] 4 [/SUP], Ying Lu[SUP] 4 8 [/SUP], Wei Pang[SUP] 4 [/SUP], Yong-Tang Zheng[SUP] 9 [/SUP], Jia Li[SUP] 10 11 12 [/SUP], Lei-Ke Zhang[SUP] 13 [/SUP], Zhaobing Gao[SUP] 14 15 16 17 [/SUP]
Affiliations
Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a global pandemic. Antibody resistance dampens neutralizing antibody therapy and threatens current global Coronavirus (COVID-19) vaccine campaigns. In addition to the emergence of resistant SARS-CoV-2 variants, little is known about how SARS-CoV-2 evades antibodies. Here, we report a novel mechanism of extracellular vesicle (EV)-mediated cell-to-cell transmission of SARS-CoV-2, which facilitates SARS-CoV-2 to escape from neutralizing antibodies. These EVs, initially observed in SARS-CoV-2 envelope protein-expressing cells, are secreted by various SARS-CoV-2-infected cells, including Vero E6, Calu-3, and HPAEpiC cells, undergoing infection-induced pyroptosis. Various SARS-CoV-2-infected cells produce similar EVs characterized by extra-large sizes (1.6-9.5 μm in diameter, average diameter > 4.2 μm) much larger than previously reported virus-generated vesicles. Transmission electron microscopy analysis and plaque assay reveal that these SARS-CoV-2-induced EVs contain large amounts of live virus particles. In particular, the vesicle-cloaked SARS-CoV-2 virus is resistant to neutralizing antibodies and able to reinfect naïve cells independent of the reported receptors and cofactors. Consistently, the constructed 3D images show that intact EVs could be taken up by recipient cells directly, supporting vesicle-mediated cell-to-cell transmission of SARS-CoV-2. Our findings reveal a novel mechanism of receptor-independent SARS-CoV-2 infection via cell-to-cell transmission, provide new insights into antibody resistance of SARS-CoV-2 and suggest potential targets for future antiviral therapeutics.
. 2023 Jan 6;9(1):2.
doi: 10.1038/s41421-022-00510-2.
Extracellular vesicles mediate antibody-resistant transmission of SARS-CoV-2
Bingqing Xia[SUP] #[/SUP][SUP] 1 2 [/SUP], Xiaoyan Pan[SUP] #[/SUP][SUP] 3 [/SUP], Rong-Hua Luo[SUP] #[/SUP][SUP] 4 [/SUP], Xurui Shen[SUP] #[/SUP][SUP] 5 6 [/SUP], Shuangqu Li[SUP] 5 6 [/SUP], Yi Wang[SUP] 5 6 [/SUP], Xiaoli Zuo[SUP] 5 [/SUP], Yan Wu[SUP] 3 [/SUP], Yingqi Guo[SUP] 7 [/SUP], Gengfu Xiao[SUP] 3 [/SUP], Qiguang Li[SUP] 5 6 [/SUP], Xin-Yan Long[SUP] 4 8 [/SUP], Xiao-Yan He[SUP] 4 8 [/SUP], Hong-Yi Zheng[SUP] 4 [/SUP], Ying Lu[SUP] 4 8 [/SUP], Wei Pang[SUP] 4 [/SUP], Yong-Tang Zheng[SUP] 9 [/SUP], Jia Li[SUP] 10 11 12 [/SUP], Lei-Ke Zhang[SUP] 13 [/SUP], Zhaobing Gao[SUP] 14 15 16 17 [/SUP]
Affiliations
- PMID: 36609376
- DOI: 10.1038/s41421-022-00510-2
Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a global pandemic. Antibody resistance dampens neutralizing antibody therapy and threatens current global Coronavirus (COVID-19) vaccine campaigns. In addition to the emergence of resistant SARS-CoV-2 variants, little is known about how SARS-CoV-2 evades antibodies. Here, we report a novel mechanism of extracellular vesicle (EV)-mediated cell-to-cell transmission of SARS-CoV-2, which facilitates SARS-CoV-2 to escape from neutralizing antibodies. These EVs, initially observed in SARS-CoV-2 envelope protein-expressing cells, are secreted by various SARS-CoV-2-infected cells, including Vero E6, Calu-3, and HPAEpiC cells, undergoing infection-induced pyroptosis. Various SARS-CoV-2-infected cells produce similar EVs characterized by extra-large sizes (1.6-9.5 μm in diameter, average diameter > 4.2 μm) much larger than previously reported virus-generated vesicles. Transmission electron microscopy analysis and plaque assay reveal that these SARS-CoV-2-induced EVs contain large amounts of live virus particles. In particular, the vesicle-cloaked SARS-CoV-2 virus is resistant to neutralizing antibodies and able to reinfect naïve cells independent of the reported receptors and cofactors. Consistently, the constructed 3D images show that intact EVs could be taken up by recipient cells directly, supporting vesicle-mediated cell-to-cell transmission of SARS-CoV-2. Our findings reveal a novel mechanism of receptor-independent SARS-CoV-2 infection via cell-to-cell transmission, provide new insights into antibody resistance of SARS-CoV-2 and suggest potential targets for future antiviral therapeutics.